secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001193125-23-106984
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte raises $544.5M net via public offering of stock and pre-funded warrants
-------------------------------------------------------------------------------

- Issued 11.2M shares at $41.00 and pre-funded warrants for 1M shares at $40.999 each.
- Underwriters exercised option to purchase additional 1.83M shares, increasing total proceeds.
- Net proceeds expected to be $544.5M after underwriting discounts and expenses.
- Closing expected April 21, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523106984/0001193125-23-106984-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523106984/d490519d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-106984

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer